Target intelligence / Profile preview

Intestinal tight junction protein

Molecular classification
Other (for the group), Individual members: Transmembrane protein (Claudins, Occludin, JAMs), Scaffolding protein (ZO family), Immunoglobulin superfamily (JAMs)
01

Overview

Intestinal tight junction proteins form a complex, dynamic multi-protein structure at the apical-most region of the epithelial lateral membrane. Their primary role is to seal the paracellular space between intestinal epithelial cells, maintaining the selective permeability barrier that regulates the passage of ions, nutrients, and water, while preventing pathogen and toxin influx. Major components include claudins (the backbone of the seal), occludin, and junctional adhesion molecules (JAMs), each of which links to intracellular scaffolding proteins like zonula occludens (ZO) that connect to the cytoskeleton[1][2][3][4][6][10]. Tight junction protein dysfunction or altered expression is implicated in a broad spectrum of diseases, including intestinal inflammation, infections, and cancer. These proteins are a therapeutic interest both as potential drug targets and as biomarkers for barrier integrity and disease progression. However, since "intestinal tight junction proteins" is a group descriptor, more precise identification of individual members is required for specific drug development or clinical application.

Other names
Tight junction proteinTJ proteinIntestinal TJ proteinIntestinal barrier protein
02

Mechanism of action

Modulation of tight junction assembly/disassembly; Stabilization or disruption of protein–protein interactions; Regulation of phosphorylation status (notably JAM-A phosphorylation affects permeability); Immunomodulatory effects by modifying barrier antigen flow.

03

Biological functions

Maintain intestinal epithelial barrier integrityRegulate paracellular permeabilityControl cell polaritySignal transduction at epithelial junctionsImmune response regulation (especially during inflammation)Scaffold for cytoskeletal anchoring
04

Disease associations

Inflammation (especially inflammatory bowel disease)Cancer (colorectal, gastric)Infection (e.g., Hepatitis C virus entry)Metabolic disease (diabetes, obesity, liver disease linked to barrier dysfunction)Other (skin, lung, and liver diseases associated with barrier dysfunction)
05

Safety considerations

Risk of compromised barrier function resulting in increased permeability to pathogens, toxins, and antigensPotential to promote inflammation or tumor metastasis if barrier is weakenedEffects may extend beyond intestine (systemic complications, e.g., liver disease, systemic inflammation)
06

Interacting drugs

No approved small molecules specifically target the entire protein group

3 more in the full profile.

07

Biomarkers

Levels of specific tight junction proteins (e.g., claudin-1, occludin, JAM-A) in tissue or serumTight junction phosphorylation state (e.g., JAM-A Y280)Transepithelial electrical resistance (TEER) as a functional readout, especially in research

Beyond the preview

Go deeper on Intestinal tight junction protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal tight junction protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call